The Hydra self-expanding transcatheter heart valve showed excellent 5-year durability, sustained hemodynamics, and acceptable survival in severe aortic stenosis patients.
Does the Hydra Self-Expanding Transcatheter Heart Valve provide long-term safety and durability in patients with severe aortic stenosis?
The Hydra self-expanding transcatheter heart valve shows favorable 5-year safety, durability, and hemodynamic performance in patients with severe aortic stenosis.
Absolute Event Rate: 0% vs 0%
The 5-year results from the long-term follow-up cohort of the Hydra CE study established excellent valve durability and sustained hemodynamic performance. The study demonstrated favorable long-term safety and clinical performance of the Hydra THV, with acceptable survival rates at 5-year follow-up.
Bajoras et al. (Mon,) reported a other. The Hydra self-expanding transcatheter heart valve showed excellent 5-year durability, sustained hemodynamics, and acceptable survival in severe aortic stenosis patients.